Transit Scientific
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Transit Scientific - overview
Established
2016
Location
Salt Lake City, UT, US
Primary Industry
Medical Devices & Equipment
About
Based in Utah, US, and founded in 2016, Transit Scientific operates as a commercial-stage medical device company that designs, develops, and commercializes medical devices. In February 2021, Transit Scientific raised series A funding led by an individual investor. As of November 2022, the company is led by its CEO Greg Method. Transit Scientific develops an XO Score angioplasty scoring-cutting platform that converts off-the-shelf* regular angioplasty balloons into scoring, cutting, and infusion vessel prep devices.
The device is indicated for the treatment of peripheral vascular stenosis including hemodialysis fistulas and grafts; XO Cross 0. 014" and 0. 035" microcatheter platform is a non-tapered exoskeleton based micro-catheter technology designed to improve torque response, trackability, and control. The company plans to use the series A funding for expansion.
Primary Industry
Medical Devices & Equipment
Sub Industries
Cardiology, Surgical Devices
Website
www.xoscore.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Transit Scientific - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.